Drugs to Which FDA has Granted Pediatric Exclusivity for Pediatric Studies under Section 505A of the Federal Food, Drug, and Cosmetic Act
NOTE: This list simply identifies approved active drugs with sponsors to which FDA has granted exclusivity for pediatric studies. Only applications held by the identified sponsor were granted pediatric exclusivity. This page is updated each time a drug has been granted pediatric exclusivity.
- Total Exclusivity Determinations = 300
- Total Approved Active Moieties Granted Exclusivity = 266
- Total Approved Drugs Granted Exclusivity = 280
Pediatric Exclusivity Determinations List
April 2022 (PDF - 92 KB)